Recent Peptide Publications

The Novo Nordisk Foundation Center for Protein Design has just moved into its new labs and offices at the University of Copenhagen, with an official inauguration still ahead. Led by Professor Dek Woolfson, a Fellow of the Royal Society and longtime American Peptide Symposium speaker, the center brings biologists, chemists, drug designers, and computer scientists together to design proteins nature never evolved. Built on a grant of roughly 109 million US dollars, it is one of the clearest signs yet that protein design has become a global scientific priority.

Radiopharmaceuticals have emerged as a rapidly evolving field at the interface of medicinal chemistry, molecular imaging, and targeted therapy. Progress in radiopharmaceutical development and translational imaging has rapidly expanded the range of diagnostic and therapeutic tools available for cancer, neurological, cardiovascular, and inflammatory diseases.

ACS Medicinal Chemistry Letters invites submissions for a Special Issue dedicated to Radiopharmaceuticals, highlighting advances in design, synthesis, biological evaluation, and clinical translation of radiolabeled agents.

The American Peptide Society congratulates Laura L. Kiessling and Ronald T. Raines of MIT on receiving the 2026 van 't Hoff Lectureship Award from the Royal Netherlands Academy of Arts and Sciences. Named for the first Nobel laureate in Chemistry, the award honors leading scientists for innovative research. Raines, a past recipient of the Society's Vincent du Vigneaud Award, and Kiessling were recognized at the 2026 van 't Hoff Symposium on Chirality in the Netherlands.